Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia (2019)
- Authors:
- Autor USP: SANTOS FILHO, RAUL DIAS DOS - FM
- Unidade: FM
- DOI: 10.1016/j.atherosclerosis.2018.11.017
- Subjects: HIPERCOLESTEROLEMIA; OLIGONUCLEOTÍDEOS; ENSAIO CLÍNICO CONTROLADO RANDOMIZADO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Atherosclerosis
- ISSN: 0021-9150
- Volume/Número/Paginação/Ano: v. 280, p. 109-117, 2019
- Este periódico é de assinatura
- Este artigo NÃO é de acesso aberto
- Cor do Acesso Aberto: closed
-
ABNT
REESKAMP, Laurens F et al. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, v. 280, p. 109-117, 2019Tradução . . Disponível em: https://doi.org/10.1016/j.atherosclerosis.2018.11.017. Acesso em: 28 mar. 2024. -
APA
Reeskamp, L. F., Kastelein, J. J. P., Moriarty, P. M., Duell, P. B., Catapano, A. L., Santos Filho, R. D. dos, & Ballantyne, C. M. (2019). Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia. Atherosclerosis, 280, 109-117. doi:10.1016/j.atherosclerosis.2018.11.017 -
NLM
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.11.017 -
Vancouver
Reeskamp LF, Kastelein JJP, Moriarty PM, Duell PB, Catapano AL, Santos Filho RD dos, Ballantyne CM. Safety and efficacy of mipomersen in patients with heterozygous familial hypercholesterolemia [Internet]. Atherosclerosis. 2019 ; 280 109-117.[citado 2024 mar. 28 ] Available from: https://doi.org/10.1016/j.atherosclerosis.2018.11.017 - Foi com muita satisfação que recebemos o convite dos ...[Apresentação]
- Relation of Uric Acid to Serum Levels of High-Sensitivity C-Reactive Protein, Triglycerides, and High-Density Lipoprotein Cholesterol and to Hepatic Steatosis
- Homozygous familial hypercholesterolemia: Current perspectives on diagnosis and treatment
- Elevated uric acid, the metabolic syndrome and cardiovascular disease [Editorial]: cause, consequence, or just a not so innocent bystander?
- Lipid-lowering treatment for homozygous familial hypercholesterolaemia [Carta]
- Statin Use Is Not Associated With Presence of and Severity of Nonalcoholic Fatty Liver Disease
- A systematic review: Burden and severity of subclinical cardiovascular disease among those with nonalcoholic fatty liver; Should we care?
- Relation of Hepatic Steatosis to Atherogenic Dyslipidemia
- Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society
- Cigarette smoking worsens systemic inflammation in persons with metabolic syndrome
Informações sobre o DOI: 10.1016/j.atherosclerosis.2018.11.017 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas